The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Interventional Tumor Ablation-Global Market Insights and Sales Trends 2025
Synopsis
Interventional tumor ablation is a minimally invasive medical procedure performed to treat certain types of tumors. It involves the use of various techniques to destroy or eliminate tumors without the need for open surgery. The goal of interventional tumor ablation is to selectively target and destroy tumor cells while minimizing damage to surrounding healthy tissues.
The global Interventional Tumor Ablation market size is expected to reach US$ 2940.8 million by 2029, growing at a CAGR of 9.3% from 2023 to 2029. The market is mainly driven by the significant applications of Interventional Tumor Ablation in various end use industries. The expanding demands from the Hospitals And Clinics, Outpatient Surgery Center and Others,, are propelling Interventional Tumor Ablation market. Radiofrequency Ablation, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Microwave Ablation segment is estimated at % CAGR for the next seven-year period.
There has been an increasing demand for minimally invasive treatment options for tumors. Interventional tumor ablation techniques, such as radiofrequency ablation, microwave ablation, cryoablation, and laser ablation, offer less invasive alternatives to traditional surgery. Patients often prefer these procedures due to their shorter recovery times, reduced complications, and the potential to preserve organ function.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Interventional Tumor Ablation, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Interventional Tumor Ablation market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Interventional Tumor Ablation market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Interventional Tumor Ablation sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Interventional Tumor Ablation covered in this report include Boston Scientific Corporation, Johnson & Johnson, Medtronic Plc, Varian Medical Systems, EDAP TMS S.A., AngioDynamics, CASCINATION AG, Merit Medical Systems and STARmed, etc.
The global Interventional Tumor Ablation market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Boston Scientific Corporation
Johnson & Johnson
Medtronic Plc
Varian Medical Systems
EDAP TMS S.A.
AngioDynamics
CASCINATION AG
Merit Medical Systems
STARmed
Global Interventional Tumor Ablation market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Interventional Tumor Ablation market, Segment by Type:
Radiofrequency Ablation
Microwave Ablation
Cryoablation
Irreversible Electroporation Ablation
Global Interventional Tumor Ablation market, by Application
Hospitals And Clinics
Outpatient Surgery Center
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Interventional Tumor Ablation companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Interventional tumor ablation is a minimally invasive medical procedure performed to treat certain types of tumors. It involves the use of various techniques to destroy or eliminate tumors without the need for open surgery. The goal of interventional tumor ablation is to selectively target and destroy tumor cells while minimizing damage to surrounding healthy tissues.
The global Interventional Tumor Ablation market size is expected to reach US$ 2940.8 million by 2029, growing at a CAGR of 9.3% from 2023 to 2029. The market is mainly driven by the significant applications of Interventional Tumor Ablation in various end use industries. The expanding demands from the Hospitals And Clinics, Outpatient Surgery Center and Others,, are propelling Interventional Tumor Ablation market. Radiofrequency Ablation, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Microwave Ablation segment is estimated at % CAGR for the next seven-year period.
There has been an increasing demand for minimally invasive treatment options for tumors. Interventional tumor ablation techniques, such as radiofrequency ablation, microwave ablation, cryoablation, and laser ablation, offer less invasive alternatives to traditional surgery. Patients often prefer these procedures due to their shorter recovery times, reduced complications, and the potential to preserve organ function.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Interventional Tumor Ablation, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Interventional Tumor Ablation market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Interventional Tumor Ablation market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Interventional Tumor Ablation sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Interventional Tumor Ablation covered in this report include Boston Scientific Corporation, Johnson & Johnson, Medtronic Plc, Varian Medical Systems, EDAP TMS S.A., AngioDynamics, CASCINATION AG, Merit Medical Systems and STARmed, etc.
The global Interventional Tumor Ablation market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Boston Scientific Corporation
Johnson & Johnson
Medtronic Plc
Varian Medical Systems
EDAP TMS S.A.
AngioDynamics
CASCINATION AG
Merit Medical Systems
STARmed
Global Interventional Tumor Ablation market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Interventional Tumor Ablation market, Segment by Type:
Radiofrequency Ablation
Microwave Ablation
Cryoablation
Irreversible Electroporation Ablation
Global Interventional Tumor Ablation market, by Application
Hospitals And Clinics
Outpatient Surgery Center
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Interventional Tumor Ablation companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Interventional Tumor Ablation
1.1 Interventional Tumor Ablation Market Overview
1.1.1 Interventional Tumor Ablation Product Scope
1.1.2 Interventional Tumor Ablation Market Status and Outlook
1.2 Global Interventional Tumor Ablation Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Interventional Tumor Ablation Market Size by Region (2018-2029)
1.4 Global Interventional Tumor Ablation Historic Market Size by Region (2018-2023)
1.5 Global Interventional Tumor Ablation Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Interventional Tumor Ablation Market Size (2018-2029)
1.6.1 North America Interventional Tumor Ablation Market Size (2018-2029)
1.6.2 Europe Interventional Tumor Ablation Market Size (2018-2029)
1.6.3 Asia-Pacific Interventional Tumor Ablation Market Size (2018-2029)
1.6.4 Latin America Interventional Tumor Ablation Market Size (2018-2029)
1.6.5 Middle East & Africa Interventional Tumor Ablation Market Size (2018-2029)
2 Interventional Tumor Ablation Market by Type
2.1 Introduction
2.1.1 Radiofrequency Ablation
2.1.2 Microwave Ablation
2.1.3 Cryoablation
2.1.4 Irreversible Electroporation Ablation
2.2 Global Interventional Tumor Ablation Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Interventional Tumor Ablation Historic Market Size by Type (2018-2023)
2.2.2 Global Interventional Tumor Ablation Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Interventional Tumor Ablation Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Interventional Tumor Ablation Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Interventional Tumor Ablation Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Interventional Tumor Ablation Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Interventional Tumor Ablation Revenue Breakdown by Type (2018-2029)
3 Interventional Tumor Ablation Market Overview by Application
3.1 Introduction
3.1.1 Hospitals And Clinics
3.1.2 Outpatient Surgery Center
3.1.3 Others
3.2 Global Interventional Tumor Ablation Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Interventional Tumor Ablation Historic Market Size by Application (2018-2023)
3.2.2 Global Interventional Tumor Ablation Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Interventional Tumor Ablation Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Interventional Tumor Ablation Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Interventional Tumor Ablation Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Interventional Tumor Ablation Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Interventional Tumor Ablation Revenue Breakdown by Application (2018-2029)
4 Interventional Tumor Ablation Competition Analysis by Players
4.1 Global Interventional Tumor Ablation Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Interventional Tumor Ablation as of 2022)
4.3 Date of Key Players Enter into Interventional Tumor Ablation Market
4.4 Global Top Players Interventional Tumor Ablation Headquarters and Area Served
4.5 Key Players Interventional Tumor Ablation Product Solution and Service
4.6 Competitive Status
4.6.1 Interventional Tumor Ablation Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Boston Scientific Corporation
5.1.1 Boston Scientific Corporation Profile
5.1.2 Boston Scientific Corporation Main Business
5.1.3 Boston Scientific Corporation Interventional Tumor Ablation Products, Services and Solutions
5.1.4 Boston Scientific Corporation Interventional Tumor Ablation Revenue (US$ Million) & (2018-2023)
5.1.5 Boston Scientific Corporation Recent Developments
5.2 Johnson & Johnson
5.2.1 Johnson & Johnson Profile
5.2.2 Johnson & Johnson Main Business
5.2.3 Johnson & Johnson Interventional Tumor Ablation Products, Services and Solutions
5.2.4 Johnson & Johnson Interventional Tumor Ablation Revenue (US$ Million) & (2018-2023)
5.2.5 Johnson & Johnson Recent Developments
5.3 Medtronic Plc
5.3.1 Medtronic Plc Profile
5.3.2 Medtronic Plc Main Business
5.3.3 Medtronic Plc Interventional Tumor Ablation Products, Services and Solutions
5.3.4 Medtronic Plc Interventional Tumor Ablation Revenue (US$ Million) & (2018-2023)
5.3.5 Varian Medical Systems Recent Developments
5.4 Varian Medical Systems
5.4.1 Varian Medical Systems Profile
5.4.2 Varian Medical Systems Main Business
5.4.3 Varian Medical Systems Interventional Tumor Ablation Products, Services and Solutions
5.4.4 Varian Medical Systems Interventional Tumor Ablation Revenue (US$ Million) & (2018-2023)
5.4.5 Varian Medical Systems Recent Developments
5.5 EDAP TMS S.A.
5.5.1 EDAP TMS S.A. Profile
5.5.2 EDAP TMS S.A. Main Business
5.5.3 EDAP TMS S.A. Interventional Tumor Ablation Products, Services and Solutions
5.5.4 EDAP TMS S.A. Interventional Tumor Ablation Revenue (US$ Million) & (2018-2023)
5.5.5 EDAP TMS S.A. Recent Developments
5.6 AngioDynamics
5.6.1 AngioDynamics Profile
5.6.2 AngioDynamics Main Business
5.6.3 AngioDynamics Interventional Tumor Ablation Products, Services and Solutions
5.6.4 AngioDynamics Interventional Tumor Ablation Revenue (US$ Million) & (2018-2023)
5.6.5 AngioDynamics Recent Developments
5.7 CASCINATION AG
5.7.1 CASCINATION AG Profile
5.7.2 CASCINATION AG Main Business
5.7.3 CASCINATION AG Interventional Tumor Ablation Products, Services and Solutions
5.7.4 CASCINATION AG Interventional Tumor Ablation Revenue (US$ Million) & (2018-2023)
5.7.5 CASCINATION AG Recent Developments
5.8 Merit Medical Systems
5.8.1 Merit Medical Systems Profile
5.8.2 Merit Medical Systems Main Business
5.8.3 Merit Medical Systems Interventional Tumor Ablation Products, Services and Solutions
5.8.4 Merit Medical Systems Interventional Tumor Ablation Revenue (US$ Million) & (2018-2023)
5.8.5 Merit Medical Systems Recent Developments
5.9 STARmed
5.9.1 STARmed Profile
5.9.2 STARmed Main Business
5.9.3 STARmed Interventional Tumor Ablation Products, Services and Solutions
5.9.4 STARmed Interventional Tumor Ablation Revenue (US$ Million) & (2018-2023)
5.9.5 STARmed Recent Developments
6 North America
6.1 North America Interventional Tumor Ablation Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Interventional Tumor Ablation Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Interventional Tumor Ablation Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Interventional Tumor Ablation Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Interventional Tumor Ablation Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Interventional Tumor Ablation Market Dynamics
11.1 Interventional Tumor Ablation Industry Trends
11.2 Interventional Tumor Ablation Market Drivers
11.3 Interventional Tumor Ablation Market Challenges
11.4 Interventional Tumor Ablation Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
